Generics & Biosimilars | Association for Accessible Medicines
AAM All Access Podcast - Dan Leonard speaks to AAM's Lisa Parks and Monét Stanford
  • AAM All Access Podcast
    AAM All Access Podcast: Pharmacists Month
    AAM CEO Dan Leonard is joined by Sciences & Regulatory Affairs VP Lisa Parks and Policy Director Monét Stanford—both registered pharmacists—to talk about the role of pharmacists in patient care and the future of pharmacy.
  • GRx+Biosims 2021 Welcome Gift
    GRx+Biosims 2021
    Register for GRx+Biosims 2021 today to receive your special welcome gift. Supplies are limited.
  • 2nd Annual Global Biosimilars Week
    Global Biosimilars Week 2021
    Save the Date! The second annual #GlobalBiosimilarsWeek to celebrate the advancement of biosimilars across the world will be held November 1-5!
  • AAM 2021 U.S. Generic and Biosimilar Medicines Savings Report. October 2021.
    2021 U.S. Generic and Biosimilar Medicines Savings Report
    Report reveals continued savings growth through lower-cost generic and biosimilar competition. The findings reinforce the outsized importance of the industry delivering lifesaving & health-managing medicines.
  • Pharmacist holding an Rx bottle and talking to a patient
    U.S. Generic and Biosimilar Savings Totaled a Record $338 Billion in 2020
    AAM releases topline findings from its forthcoming 2021 U.S. Generic and Biosimilar Medicines Savings report highlighting the value of generic and biosimilar medicines.
  • Janet Woodcock, M.D. Acting Commissioner, FDA
    FDA Acting Commissioner to Speak at GRx+Biosims
    Dr. Janet Woodcock will bring invaluable insights on generics and biosimilars during this public health emergency. Sign up for GRx+Biosims 2021 now and enjoy $300 in savings.
  • GRx+Biosims 2021: Generics & Biosimilars Conference — Progress + Process
    GRx+Biosims 2021
    Hear the latest from top-in-their-field speakers and government officials, connect with peers from around the world and explore new learning tracks in the generics and biosimilars industry. November 8-10, 2021. Sign up for GRx+Biosims 2021 now and enjoy $300 in savings!
    Watch Video
  • AAM All Access Podcast
    AAM All Access Podcast: Dan Leonard and Jeff Watson
    Dan Leonard speaks with Apotex President and CEO Jeff Watson on the history and vision of the manufacturer and a future of “tremendous opportunity” for generics.
  • ""
    Industry Response to COVID-19
    The coronavirus (COVID-19) pandemic is disrupting everyday life around the world and imposing unprecedented stress on our health care system. Here are some responses and resources from the U.S. generics and biosimilars industry.
  • AAM Report: New Generics Are Less Available in Medicare Than Commercial Plans
    New Generics Are Less Available in Medicare Than Commercial Plans
    AAM releases a new report confirming Medicare Part D plans continue to fail to get new generics to patients.
  • RxFacts
    What We Know—and What We Don’t
    In the past two decades, misunderstood and exaggerated stats regarding the generics supply chain have been cited.
  • Take with Confidence
    Take With Confidence
    Generic Prescription Drugs: Your Health. Our Commitment.
  • AAM Patient Report: Voices of Access
    Patient Stories: Voices of Access
    AAM's Voices of Access report features patients across the country who tell the impact of accessible generic and biosimilar medicines.
  • Interactive Savings Map 2020
    Health Care Savings, State by State
    The average state saved $6.1 billion from the use of generic drugs in 2019. How much did your state save?

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.